Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA

NCT04183712 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Gallbladder Carcinoma

Interventions

DRUG: gemcitabine and oxaliplatin.
DRUG: Afatinib

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]